As the threat of counterfeiting continues to torment industry stakeholders and patients, more strategic approaches to ...

Dr. Peter Marks, the former director of the FDA’s Center for Biologics Evaluation and Research, urged public health leaders ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...